Oncolytics Biotech Inc. Share Price Nasdaq
Equities
ONCY
CA6823108759
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.07 USD | -0.93% | -1.83% | -20.74% |
Sales 2024 * | 1M 733K 57.59M | Sales 2025 * | 8.12M 5.96M 468M | Capitalization | 111M 81.21M 6.38B |
---|---|---|---|---|---|
Net income 2024 * | -34M -24.93M -1.96B | Net income 2025 * | -39M -28.6M -2.25B | EV / Sales 2024 * | 111 x |
Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 13.6 x |
P/E ratio 2024 * |
-3.67
x | P/E ratio 2025 * |
-3.97
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 96.1% |
Latest transcript on Oncolytics Biotech Inc.
1 day | -0.93% | ||
1 week | -1.83% | ||
1 month | -4.46% | ||
3 months | -4.46% | ||
6 months | -24.65% | ||
Current year | -20.74% |
Managers | Title | Age | Since |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 10/05/11 |
Kirk Look
DFI | Director of Finance/CFO | - | 31/03/03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 06/09/22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 01-08 |
Bernd Seizinger
BRD | Director/Board Member | 67 | 07/06/15 |
Date | Price | Change | Volume |
---|---|---|---|
31/05/24 | 1.07 | -0.93% | 94,788 |
30/05/24 | 1.08 | -0.92% | 82,055 |
29/05/24 | 1.09 | -0.91% | 175,038 |
28/05/24 | 1.1 | +0.92% | 184,281 |
24/05/24 | 1.09 | +2.83% | 250,852 |
Delayed Quote Nasdaq, May 31, 2024 at 09:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.52% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B |
- Stock Market
- Equities
- ONC Stock
- ONCY Stock